SecBot SecBot
← Back to Analyst Consensus
AQST Buy

Aquestive Therapeutics, Inc.

Current Price —
Implied Upside —
Analysts 15

30-Day Momentum

▲ 0 upgrades  /  ▼ 0 downgrades  /  0 reiterations  from 0 firms

Next Earnings

Nov 9, 2026 (14 days)

Rating Timeline

Date ▼FirmActionFrom → To RatingPrice TargetFirm Rating
Aug 24, 2026HC Wainwright & Co.reiterateBuy → Buy—44%
Nov 7, 2025Piper SandlermaintainOverweight → Overweight$854%
Oct 9, 2025JMP SecuritiesmaintainMarket Outperform → Market Outperform$1253%
Sep 8, 2025OppenheimermaintainOutperform → Outperform$852%
Jun 17, 2025HC Wainwright & Co.reiterateBuy → Buy$1044%
May 15, 2025HC Wainwright & Co.reiterateBuy → Buy$1044%
Apr 2, 2025HC Wainwright & Co.reiterateBuy → Buy$1044%
Mar 10, 2025HC Wainwright & Co.reiterateBuy → Buy$1044%
Mar 7, 2025Lake StreetmaintainBuy → Buy$847%
Dec 20, 2024HC Wainwright & Co.reiterateBuy → Buy$1044%
Dec 17, 2024Cantor Fitzgeraldinitiate— → Overweight$1750%
Nov 11, 2024HC Wainwright & Co.reiterateBuy → Buy$1044%
Nov 6, 2024HC Wainwright & Co.reiterateBuy → Buy$1044%
Oct 25, 2024Leerink PartnersmaintainOutperform → Outperform$1351%
Oct 25, 2024HC Wainwright & Co.reiterateBuy → Buy$1044%
Oct 8, 2024JMP SecuritiesreiterateMarket Outperform → Market Outperform$953%
Sep 30, 2024JMP SecuritiesreiterateMarket Outperform → Market Outperform$953%
Sep 30, 2024Leerink PartnersreiterateOutperform → Outperform$1251%
Sep 30, 2024HC Wainwright & Co.maintainBuy → Buy$1044%
Aug 14, 2024HC Wainwright & Co.reiterateBuy → Buy$944%
Aug 12, 2024JMP SecuritiesreiterateMarket Outperform → Market Outperform$953%
Jul 26, 2024HC Wainwright & Co.reiterateBuy → Buy$944%
Jun 26, 2024JMP SecuritiesreiterateMarket Outperform → Market Outperform$953%
Jun 5, 2024HC Wainwright & Co.reiterateBuy → Buy$944%
May 10, 2024Leerink Partnersinitiate— → Outperform$851%
May 9, 2024HC Wainwright & Co.reiterateBuy → Buy$944%
Apr 30, 2024HC Wainwright & Co.reiterateBuy → Buy$944%
Apr 11, 2024Piper Sandlerinitiate— → Overweight$1054%
Apr 5, 2024HC Wainwright & Co.reiterateBuy → Buy$944%
Mar 28, 2024Raymond Jamesinitiate— → Outperform$754%
Mar 18, 2024HC Wainwright & Co.maintainBuy → Buy$944%
Mar 15, 2024JMP SecuritiesmaintainOutperform → Outperform$1053%
Mar 11, 2024HC Wainwright & Co.maintainBuy → Buy$744%
Mar 7, 2024WedbushmaintainOutperform → Outperform$958%
Mar 7, 2024Lake StreetmaintainBuy → Buy$847%
Nov 8, 2023HC Wainwright & Co.maintainBuy → Buy$644%
Oct 10, 2023WedbushreiterateOutperform → Outperform$458%
Oct 10, 2023HC Wainwright & Co.reiterateBuy → Buy$544%
Sep 22, 2023WedbushreiterateOutperform → Outperform$458%
Sep 22, 2023HC Wainwright & Co.reiterateBuy → Buy$544%
Sep 21, 2023JMP SecuritiesreiterateMarket Outperform → Market Outperform$853%
Jul 31, 2023HC Wainwright & Co.reiterateBuy → Buy$544%
Jun 30, 2023JMP SecuritiesreiterateMarket Outperform → Market Outperform$853%
Jun 21, 2023HC Wainwright & Co.reiterateBuy → Buy$544%
Jun 5, 2023HC Wainwright & Co.reiterateBuy → Buy$544%
Mar 9, 2023WedbushupgradeNeutral → Outperform$458%
Nov 4, 2022Alliance Global Partnersmaintain— → Buy$741%
Sep 7, 2022Oppenheimerinitiate— → Outperform$8.552%
Sep 6, 2022HC Wainwright & Co.maintain— → Buy$544%
Aug 30, 2022Alliance Global Partnersinitiate— → Buy$1041%

Price Target Trend

Jun 6, 2026 Oct 26, 2026

EPS Estimates

0y —
+1q —
+1y —
0q —

Cross-Platform Signals

No cross-platform signals in the last 90 days

Fresh Analyst Detail

Price targets, earnings estimates, and firm actions for this ticker — updated within the last 24 hours.

Subscribe for Full Access